THE COST OF ABSENTEEISM AND SHORT-TERM DISABILITY ASSOCIATED WITH COLORECTAL CANCER- A CASE-CONTROL STUDY
Author(s)
Yaldo A1, Seal B2, Lage MJ31Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ, USA, 2Bayer HealthCare Pharmaceuticals, Inc., Pine Brook, NJ, USA, 3HealthMetrics Outcomes Research, Delray Beach, FL, USA
OBJECTIVES: Examine the incremental costs of absenteeism and short-term disability associated with colorectal cancer (CRC). METHODS: The MarketScan Commercial Claims and Encounters (CCAE) and Health and Productivity Management (HPM) databases were used to identify patients age 18-64 diagnosed with CRC, with first such date identified as the index date. Patients were also required to have continuous insurance coverage and be included in the HPM database from 6 months prior through 12 months post index date. These cases were matched 1:1 without replacement based upon age, sex, and region of residence and controls were assigned an identical index date as their matched case. Absenteeism costs in the 1 year post diagnosis were then estimated using a generalized linear model with log link and variance function determined by modified Park test (GLM). Short-term disability costs were estimated with a two part model where the first part utilized a logistic model to determine the probability of having a short-term disability claim and the second part is a GLM model for patients who had such a claim. The analyses controlled for patient characteristics, prior medical costs, and general health. RESULTS: Patients with colorectal cancer in this study (N=165) were mostly male (75.76%) with a mean age of 52 years. Patients with colorectal cancer were significantly less likely to be insured via point-of-service insurance (45.45% v 79.39%; p<0.0001) but more likely to be insured via a preferred provider organization (44.24% v 7.88%; P<0.0001) compared to their healthy matches (N=165). After controlling for patient characteristics, prior medical costs and general health, patients with colorectal cancer experienced, on average, $6,075 higher short-term disability costs (P<0.0001) and $3,633 higher absenteeism costs (P<0.0001) in the 1 year post diagnosis of CRC. CONCLUSIONS: Results indicate that CRC is associated with significant work-related productivity loss costs in the first year post diagnosis.
Conference/Value in Health Info
2012-11, ISPOR Europe 2012, Berlin, Germany
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PCN102
Topic
Economic Evaluation
Topic Subcategory
Work & Home Productivity - Indirect Costs
Disease
Oncology